The drug, Brilacidin, is a synthetic molecule developed by the University of Pennsylvania using a super computer that made nonstop calculations for 6.8 years before arriving at it. It is designed to be safe, antifungal, antiviral, antibacterial and anti-inflammatory. It is also designed to be easily incorporated into plastics and paint. It has already undergone 8 other human trials successfully and is about to start human trials for COVID-19. You still have time to build your position. Lots of room to grow.

Read these:

http://www.ipharminc.com/press-release/2021/1...esignation


http://www.ipharminc.com/press-release/2020/9...00-percent

Can’t get more de-risked than this.